Oxford Brookes University develop vaccine

Research has been conducted through their spinout company, Oxford Expression Technologies Ltd, to develop a Covid-19 vaccine. Awarded a grant by Innovate UK to work in partnership with Vaxine Pty Ltd. Covax-19® is a vaccine based on production of recombinant spike protein manufactured in insect cells and the Innovate UK grant will enable OET experts to use their technology to help Vaxine to improve the yield and scale of production.

Further reading